Clin2
NCT06986993Possibly a fitRecruiting

Semaglutide for smoking and weight in people with obesity

Tobacco Use

Treatments studied

Part of Lungs & breathing, Mental health clinical trials.

This study tests whether the medication semaglutide (similar to Ozempic/Wegovy) can help people who smoke and have obesity cut down on cigarettes, even if they aren't ready to quit. Participants will receive the drug and be monitored for changes in smoking habits and health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You smoke more than 2 cigarettes each day.
  • You have a BMI of 30 or higher (obesity).
  • You are not currently trying to quit smoking.
  • You have not taken weight-loss or diabetes medications like Ozempic or insulin in the last 6 months.
  • You do not have a history of certain medical conditions (like pancreatitis, diabetes, or thyroid cancer).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06173778Recruiting· Phase 2
Semaglutide for weight management after quitting smoking

This study tests whether the drug semaglutide (often used for weight loss) can help people who quit smoking avoid gaining weight. It's for people who are overweight or have weight-related health issues and want to stop smoking.

Austin, Texas
NCT07059377Recruiting· Phase 3
Semaglutide to help smokers with diabetes quit

This study tests if the diabetes drug semaglutide can help people with type 2 diabetes stop smoking more easily. Participants will get either semaglutide or a placebo to see if it improves quit rates.

Ottawa, Ontario
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.

NCT07323134Not yet recruiting
Semaglutide for obesity and gut health

This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.

NCT07772960Not yet recruiting· Phase 1
Semaglutide for alcohol use and weight loss

This study tests whether semaglutide, a medication that helps with weight loss, can also reduce alcohol cravings and drinking in people with alcohol use disorder. It may help you drink less and lose weight.

New Haven, Connecticut
NCT06633783Not yet recruiting· Phase 3
Semaglutide injection for weight loss study

This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).

Xuancheng, Anhui

Hear when a new Tobacco Use trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.